| Ansøgningsnr. og dato | 12759801.9 (espacenet) (Federated) (European Patent Register), 20120725 | | Patent/reg.nr. og dato | DK/EP 2736895, 20160106 | | Tilgængelighedsdato | 20140604 | | Prioritetsnr. og dato | US 201161512061 P, 20110727, US 201261591363 P, 20120127 | | EP publ. nr. og dato |
EP 2736895 20140604 | | Løbedag | | | Ansøger/indehaver | Astrazeneca AB, 151 85 Södertälje, SE | | Ansøgers ref. nr. | AST 104177-EP-EPT | | Opfinder | WARD, Richard, Andrew, AstraZeneca R & D Alderley
Alderley Park
Macclesfield Cheshire SK10 4TG, GB,
FINLAY, Maurice, Raymond, Verschoyle, AstraZeneca R & D Alderley
Alderley Park
Macclesfield Cheshire SK10 4TG, GB,
KADAMBAR, Vasantha, Krishna, AstraZeneca India Private Limited
Hebbal
Off Bellary Road
Bangalore 560024, IN,
MURUGAN, Andiappan, AstraZeneca India Private Limited
Hebbal
Off Bellary Road
Bangalore 560024, IN,
REDFEARN, Heather, Marie, AstraZeneca
Charter Way
Macclesfield
Cheshire SK10 2NA, GB,
CHUAQUI, Claudio Edmundo, AstraZeneca R&D Boston
35 Gatehouse Drive
Waltham, Massachusetts 02451, US,
BUTTERWORTH, Sam, c/o AstraZeneca R&D Alderley
Alderley Park
Macclesfield
Cheshire SK10 4TG, GB,
CHINTAKUNTLA, Chandrasekhara, Reddy, AstraZeneca India Private Limited
Hebbal
Off Bellary Road
Bangalore 560024, IN | | Fuldmægtig | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Interessent på tilknyttet sag | | | IPC-Klasse | A61K 31/437 (2006.01) , A61K 31/506 (2006.01) , A61P 35/00 (2006.01) , C07D 401/02 (2006.01) , C07D 471/04 (2006.01) | | Titel/benævnelse | 2-(2,4,5-SUBSTITUERET ANILIN)-PYRIMIDINDERIVATER SOM EGFR-MODULATORER, DER ER ANVENDELIGE TIL BEHANDLING AF CANCER | | Internationalt ansøgningsnr. | GB2012051783 | | Internationalt publ. nr. | WO2013014448 | | Relateret sag (certifikat) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
